Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis

Nutrition Research

Volumn 36, Issue 10, 2016, Pages 1105-1113

  Banerjee, Nivedita ^a   Kim, Hyemee ^a   Talcott, Stephen T ^a   Turner, Nancy D ^a   Byrne, David H ^a   Mertens Talcott, Susanne U ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Chlorogenic acid; Colon cancer; Inflammation; miR 143; mTOR; Plum; Rat

Indexed keywords

CATALASE; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 143; POLYPHENOL; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; VASCULAR CELL ADHESION MOLECULE 1; 5'-O-CAFFEOYLQUINIC ACID; ANTINEOPLASTIC AGENT; AUTACOID; AZOXYMETHANE; CHLOROGENIC ACID; MICRORNA; MIRN143 MICRORNA, RAT; MTOR PROTEIN, RAT; PLANT EXTRACT; QUINIC ACID; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PLUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ABERRANT CRYPT FOCUS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; COLON; COLON TUMOR; DIET; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ABERRANT CRYPT FOCI; ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CELL PROLIFERATION; CHLOROGENIC ACID; COLON; COLONIC NEOPLASMS; DIET; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MALE; MICRORNAS; PHOSPHORYLATION; PLANT EXTRACTS; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-AKT; PRUNUS DOMESTICA; QUINIC ACID; RATS, SPRAGUE-DAWLEY; TOR SERINE-THREONINE KINASES;

EID: 84992189557     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.06.008     Document Type: Article

References (65)

1. [1] Siegel, RL, Miller, KD, Jemal, A, Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
2. [2] Pan, MH, Lai, CS, Wu, JC, Ho, CT, Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res 55 (2011), 32–45.
3. [3] Vanamala, J, Leonardi, T, Patil, B, Taddeo, I, Murphy, M, Pike, L, et al. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis 27 (2006), 1257–1265.
4. [4] Paul, S, DeCastro, AJ, Lee, HJ, Smolarek, AK, So, JY, Simi, B, et al. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the β-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis 31 (2010), 1272–1278.
5. [5] Banerjee, N, Kim, H, Talcott, S, Mertens-Talcott, S, Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis 34 (2013), 2814–2822.
6. [6] Bouayed, J, Rammal, H, Dicko, A, Younos, C, Soulimani, R, Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J Neurol Sci 262 (2007), 77–84.
7. [7] Noratto, G, Porter, W, Byrne, D, Cisneros-Zevallos, L, Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells. J Agric Food Chem 57 (2009), 5219–5226.
8. [8] Thurow, T, Lee, S-O, Effect of chlorogenic acid and neochlorogenic acid on human colon cancer cells. Disc J 13 (2012), 86–93.
9. [9] Suberu, JO, Romero-Canelón, I, Sullivan, N, Lapkin, AA, Barker, GC, Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells. ChemMedChem 9 (2014), 2791–2797.
10. [10] Yang, JS, Liu, CW, Ma, YS, Weng, SW, Tang, NY, Wu, SH, et al. Chlorogenic acid induces apoptotic cell death in U937 leukemia cells through caspase- and mitochondria-dependent pathways. In Vivo 26 (2012), 971–978.
11. 2-induced oxidative stress in mouse blood granulocytes. J Med Food 12 (2009), 861–868.
12. [12] Vizzotto, M, Porter, W, Byrne, D, Cisneros-Zevallos, L, Polyphenols of selected peach and plum genotypes reduce cell viability and inhibit proliferation of breast cancer cells while not affecting normal cells. Food Chem 164 (2014), 363–370.
13. [13] Yang, Y, Gallaher, DD, Effect of dried plums on colon cancer risk factors in rats. Nutr Cancer 53 (2005), 117–125.
14. [14] Lea, MA, Ibeh, C, desBordes, C, Vizzotto, M, Cisneros-Zevallos, L, Byrne, DH, et al. Inhibition of growth and induction of differentiation of colon cancer cells by peach and plum phenolic compounds. Anticancer Res 28 (2008), 2067–2076.
15. [15] Liou, GY, Storz, P, Reactive oxygen species in cancer. Free Radic Res 44 (2010), 479–496.
16. [16] Zhang, YJ, Dai, Q, Sun, DF, Xiong, H, Tian, XQ, Gao, FH, et al. mTOR signaling pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol 16 (2009), 2617–2628.
17. [17] Vivanco, I, Sawyers, CL, The phosphatidylinositol 3–kinase–AKT pathway in human cancer. Nat Rev Cancer 2 (2002), 489–501.
18. [18] Morgensztern, D, McLeod, HL, PI3K/Akt/mTOR pathway as a target for cancer therapy. Anti-Cancer Drugs 16 (2005), 797–803.
19. [19] Schmelzle, T, Hall, MN, TOR, a central controller of cell growth. Cell 103 (2000), 253–262.
20. [20] Weichhart, T, Costantino, G, Poglitsch, M, Rosner, M, Zeyda, M, Stuhlmeier, KM, et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29 (2008), 565–577.
21. [21] Land, SC, Tee, AR, Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282 (2007), 20534–20543.
22. [22] Ahmad, A, Biersack, B, Li, Y, Kong, D, Bao, B, Schobert, R, et al. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anti Cancer Agents Med Chem 13 (2013), 1014–1024.
23. [23] Wu, Y, Liu, F, Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment. Anticancer Agents Med Chem 13 (2013), 1032–1038.
24. [24] Alqurashi, N, Hashimi, SM, Wei, MQ, Chemical inhibitors and microRNAs (miRNA) targeting the mammalian target of rapamycin (mTOR) pathway: potential for novel anticancer therapeutics. Int J Mol Sci 14 (2013), 3874–3900.
25. [25] Li, XM, Wang, AM, Zhang, J, Yi, H, Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 28 (2011), 1054–1057.
26. [26] Pekow, JR, Dougherty, U, Mustafi, R, Zhu, H, Kocherginsky, M, Rubin, DT, et al. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 18 (2012), 94–100.
27. [27] Xu, Q, Liu, LZ, Qian, X, Chen, Q, Jiang, Y, Li, D, et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40 (2012), 761–774.
28. [28] Guo, C, Sah, FJ, Beard, L, Willson, JKV, Markowitz, SD, Guda, K, The non-coding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3–kinase signaling and is frequently lost in Colon cancers. Genes Chromosom Cancer 47 (2008), 939–946.
29. [29] Chen, J, Wang, M, The roles of miRNA-143 in colon cancer and therapeutic implications. Transl Gastrointest Cancer 1 (2012), 169–174.
30. [30] Swain, T, Hillis, W, The phenolic constituents of Prunus domestica. I. The quantitative analysis of phenolic constituents. J Sci Food Agric 10 (1959), 63–68.
31. [31] Banerjee, N, Talcott, S, Safe, S, Mertens-Talcott, SU, Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res Treat 136 (2012), 21–34.
32. [32] Conlee, K, Stephens, M, Rowan, AN, King, LA, Carbon dioxide for euthanasia: concerns regarding pain and distress, with special reference to mice and rats. Lab Anim 39 (2005), 137–161.
33. [33] Warren, C, Paulhill, K, Davidson, L, Lupton, J, Taddeo, S, Hong, M, et al. Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J Nutr 139 (2009), 101–105.
34. [34] Leonardi, T, Vanamala, J, Taddeo, SS, Davidson, LA, Murphy, ME, Patil, BS, et al. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med 235 (2010), 710–717.
35. [35] Hong, MY, Bancroft, LK, Turner, ND, Davidson, LA, Murphy, ME, Carroll, RJ, et al. Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon. Nutr Cancer 52 (2005), 166–175.
36. [36] Kim, H, Hong, M-K, Choi, H, Moon, H-S, Lee, H-J, Chemopreventive effects of Korean red ginseng extract on rat hepatocarcinogenesis. J Cancer 6 (2015), 1–8.
37. [37] Kim, H, Banerjee, N, Ivanov, I, Pfent, CM, Prudhomme, KR, Bisson, WH, et al. Comparison of anti-inflammatory mechanisms of mango (Mangifera indica L.) and pomegranate (Punica granatum L.) in a preclinical model of colitis. Mol Nutr Food Res, 2016.
38. [38] Pretlow, TP, Barrow, BJ, Ashton, WS, O'Riordan, MA, Pretlow, TG, Jurcisek, JA, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51 (1991), 1564–1567.
39. [39] Reuter, S, Gupta, SC, Chaturvedi, MM, Aggarwal, BB, Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 49 (2010), 1603–1616.
40. [40] Oberley, TD, Oberley, LW, Antioxidant enzyme levels in cancer. Histol Histopathol 12 (1997), 525–535.
41. [41] Bird, RP, Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93 (1995), 55–71.
42. [42] Reagan-Shaw, S, Nihal, M, Ahmad, N, Dose translation from animal to human studies revisited. FASEB J 22 (2008), 659–661.
43. [43] Li, Y, Cao, Z, Zhu, H, Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 53 (2006), 6–15.
44. [44] Sabu, M, Smitha, K, Kuttan, R, Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 83 (2002), 109–116.
45. [45] Kim, HJ, Yu, M-H, Lee, I-S, Inhibitory effects of methanol extract of plum (Prunus salicina L., cv. ‘Soldam’) fruits against benzo (α) pyrene-induced toxicity in mice. Food Chem Toxicol 46 (2008), 3407–3413.
46. [46] Rupasinghe, HV, Jayasankar, S, Lay, W, Variation in total phenolics and antioxidant capacity among European plum genotypes. Sci Hortic 108 (2006), 243–246.
47. [47] Hu, Z, Yu, W, Zhao, Y, Study on the scavenging of ROS and anti-lipid peroxidation by chlorogenic acid. Food Sci 27 (2006), 128–130.
48. [48] Gonthier, M-P, Verny, M-A, Besson, C, Rémésy, C, Scalbert, A, Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 133 (2003), 1853–1859.
49. [49] Gómez-Ruiz, JÁ, Leake, DS, Ames, JM, In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55 (2007), 6962–6969.
50. [50] Srinivasan, M, Sudheer, AR, Menon, VP, Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40 (2007), 92–100.
51. [51] Mancuso, C, Santangelo, R, Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol 65 (2014), 185–195.
52. [52] Das, U, Manna, K, Sinha, M, Datta, S, Das, DK, Chakraborty, A, et al. Role of ferulic acid in the amelioration of ionizing radiation induced inflammation: a murine model. PLoS One, 9, 2014, e97599.
53. [53] Huang, M-T, Smart, RC, Wong, C-Q, Conney, AH, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48 (1988), 5941–5946.
54. [54] Lawrence, T, The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol, 1, 2009, a001651.
55. [55] Afaq, F, Malik, A, Syed, D, Maes, D, Matsui, MS, Mukhtar, H, Pomegranate fruit extract modulates UV-B–mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 81 (2005), 38–45.
56. [56] Tsujii, M, Kawano, S, Tsuji, S, Sawaoka, H, Hori, M, DuBois, RN, Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998), 705–716.
57. [57] Murakami, A, Ohigashi, H, Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121 (2007), 2357–2363.
58. [58] Jung, Y-J, Isaacs, JS, Lee, S, Trepel, J, Neckers, L, IL-1β–mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003), 2115–2117.
59. [59] Pandurangan, AK, Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev 14 (2013), 2201–2205.
60. [60] Prior, RL, E Wilkes, SRRT, Khanal, RC, X, W, Howard, LR, Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem 58 (2010), 3970–3976.
61. [61] Rains, TM, Agarwal, S, Maki, KC, Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22 (2011), 1–7.
62. [62] Kumar, SP, Roy, SJ, Tokumo, K, Reddy, BS, Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 50 (1990), 5761–5766.
63. [63] Frezza, EE, Wachtel, MS, Chiriva-Internati, M, Influence of obesity on the risk of developing colon cancer. Gut 55 (2006), 285–291.
64. [64] Yun, J, Mullarky, E, Lu, C, Bosch, KN, Kavalier, A, Rivera, K, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350 (2015), 1391–1396.
65. [65] Noguchi, S, Yasui, Y, Iwasaki, J, Kumazaki, M, Yamada, N, Naito, S, et al. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 328 (2013), 353–361.